MedTrace Logo

Phytotherapy Agent in Third Molar Surgery

NCT03335683 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2017-11-08

No results posted yet for this study

Summary

The aim of the present study was to evaluate the effect of a phytotherapy agent on clinical and inflammatory parameters, for the postoperative therapy of the impacted third molar surgery. The null hypothesis to invalidate was that, after the last follow-up, there were no variations between the phytotherapy agent and the placebo.

Conditions

  • Oral Soft Tissue Conditions

Interventions

DRUG

Lenidase

drug per os twice day for 7 days, or for 10 days

Sponsors & Collaborators

  • Gaetano Isola, DDS, PhD

    lead OTHER

Principal Investigators

  • Giovanni Matarese, DDS · Univeristy of Messina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-07
Primary Completion
2017-06-20
Completion
2017-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03335683 on ClinicalTrials.gov